Sandoz Group AG | WebDisclosure

Switch to English

10456	Sociétés
219587	Mots-clés
148969	Articles
116111	Communiqués

Accueil
Sociétés
Sandoz Group AG

COMMUNIQUÉ DE PRESSE

publié le 17/11/2025 à 07:00, il y a 6 mois 9 jours

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri®

US Market Multiple Sclerosis Biosimilar Sandoz TYRUKO
BRÈVE

publiée le 12/11/2025 à 07:40, il y a 6 mois 14 jours

Sandoz obtient une licence mondiale pour un biosimilaire du cancer du sein

Oncologie Biosimilaire Cancer Du Sein Sandoz Pertuzumab
BRÈVE

publiée le 12/11/2025 à 07:40, il y a 6 mois 14 jours

Sandoz Secures Global License for Breast Cancer Biosimilar

Oncology Biosimilar Breast Cancer Sandoz Pertuzumab
COMMUNIQUÉ DE PRESSE

publié le 12/11/2025 à 07:35, il y a 6 mois 14 jours

Sandoz signs global license agreement to commercialize breast cancer biosimilar pertuzumab
Sandoz signs global license agreement with EirGenix Inc. to commercialize biosimilar pertuzumab for HER2-positive breast cancer treatment, reinforcing its position in oncology

Agreement Biosimilar Breast Cancer Sandoz Pertuzumab
BRÈVE

publiée le 04/11/2025 à 22:10, il y a 6 mois 21 jours

Sandoz acquiert Just-Evotec Biologics pour développer ses capacités dans le domaine des biosimilaires.

Acquisition Biosimilaires Toulouse Sandoz Just-Evotec
BRÈVE

publiée le 04/11/2025 à 22:10, il y a 6 mois 21 jours

Sandoz Acquires Just-Evotec Biologics to Expand Biosimilars Capabilities

Acquisition Biosimilars Toulouse Sandoz Just-Evotec
COMMUNIQUÉ DE PRESSE

publié le 04/11/2025 à 22:05, il y a 6 mois 21 jours

Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees

Acquisition Biosimilars Sandoz Just-Evotec Biologics Continuous Manufacturing Technology
BRÈVE

publiée le 30/10/2025 à 07:05, il y a 6 mois 27 jours

Sandoz annonce une croissance de ses ventes et une révision à la hausse de ses prévisions de marge.

Croissance Des Ventes Biosimilaires Performance Régionale Orientation Financière Questions Commerciales
BRÈVE

publiée le 30/10/2025 à 07:05, il y a 6 mois 27 jours

Sandoz Reports Growth in Sales and Upgraded Margin Guidance

Financial Guidance Sales Growth Biosimilars Regional Performance Trade Issues
COMMUNIQUÉ DE PRESSE

publié le 30/10/2025 à 07:00, il y a 6 mois 27 jours

Sandoz delivers a further acceleration in sales growth; full-year margin guidance upgraded
Sandoz reports 5% growth in net sales for 9 months, with biosimilars contributing over 30%. Full-year margin guidance raised to 21-22% core EBITDA

EBITDA Net Sales Biosimilars Sandoz Margin Guidance

Les Echos

Publié le 26/05/2026 à 15:00, il y a 2 heures 19 minutes

Besluiten Gewone en Buitengewone Algemene Vergaderingen
Publié le 26/05/2026 à 15:00, il y a 2 heures 19 minutes

Resolutions Ordinary and Extraordinary General Meetings
Publié le 26/05/2026 à 07:59, il y a 9 heures 20 minutes

Saint-Gobain signe un accord de cession de son activité de distribution de carrelage dans les pays nordiques
Publié le 26/05/2026 à 07:59, il y a 9 heures 20 minutes

Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Publié le 25/05/2026 à 18:00, il y a 23 heures 19 minutes

Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 26/05/2026 à 14:30, il y a 2 heures 49 minutes

Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Publié le 26/05/2026 à 14:30, il y a 2 heures 49 minutes

Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Publié le 26/05/2026 à 14:30, il y a 2 heures 49 minutes

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
Publié le 26/05/2026 à 14:15, il y a 3 heures 4 minutes

Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Publié le 26/05/2026 à 14:00, il y a 3 heures 19 minutes

Ameriwest Critical Metals Provides Q2 2026 Corporate Update and Announces Live CEO Investor Webinar

Voir tout ACCESSWIRE

EQS Group

Publié le 26/05/2026 à 16:30, il y a 48 minutes

M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Publié le 26/05/2026 à 16:15, il y a 1 heure 4 minutes

R. STAHL AG Management Board member Dr. Claus Bischoff resigns from his office as Management Board member at his own request and for personal reasons and will leave by mutual agreement as of 31 May 20
Publié le 26/05/2026 à 16:03, il y a 1 heure 16 minutes

EQS-Adhoc: R. Stahl AG: Dr. Claus Bischoff resigns from his office as member of the Management Board of R. STAHL Aktiengesellschaft with immediate effect and will leave the company as of 31 May 2026.
Publié le 26/05/2026 à 16:01, il y a 1 heure 18 minutes

EQS-Adhoc: Tempton Personaldienstleistungen GmbH announces full redemption of bonds and the exercise of the early redemption option
Publié le 26/05/2026 à 15:37, il y a 1 heure 42 minutes

FGC plans regional rail transport in Catalonia with IVU.rail